PL3872085T3 - Sekwencje aav-przodka i ich zastosowania - Google Patents
Sekwencje aav-przodka i ich zastosowaniaInfo
- Publication number
- PL3872085T3 PL3872085T3 PL21161372.4T PL21161372T PL3872085T3 PL 3872085 T3 PL3872085 T3 PL 3872085T3 PL 21161372 T PL21161372 T PL 21161372T PL 3872085 T3 PL3872085 T3 PL 3872085T3
- Authority
- PL
- Poland
- Prior art keywords
- aav sequences
- ancestral aav
- ancestral
- sequences
- aav
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Materials For Medical Uses (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562199059P | 2015-07-30 | 2015-07-30 | |
| US201562203002P | 2015-08-10 | 2015-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3872085T3 true PL3872085T3 (pl) | 2023-06-05 |
Family
ID=57885044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21161372.4T PL3872085T3 (pl) | 2015-07-30 | 2016-07-29 | Sekwencje aav-przodka i ich zastosowania |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10738087B2 (pl) |
| EP (3) | EP4134375A1 (pl) |
| JP (2) | JP7166168B2 (pl) |
| CN (1) | CN108603235A (pl) |
| AU (1) | AU2016298394C1 (pl) |
| CA (2) | CA3126951A1 (pl) |
| DK (1) | DK3872085T5 (pl) |
| ES (1) | ES2945427T3 (pl) |
| FI (1) | FI3872085T3 (pl) |
| HK (1) | HK1254848A1 (pl) |
| HU (1) | HUE061388T2 (pl) |
| LT (1) | LT3872085T (pl) |
| NZ (1) | NZ778484A (pl) |
| PL (1) | PL3872085T3 (pl) |
| PT (1) | PT3872085T (pl) |
| WO (1) | WO2017019994A2 (pl) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE23193606T1 (de) * | 2005-04-07 | 2024-02-15 | The Trustees Of The University Of Pennsylvania | Verfahren zur erhöhung der funktion eines aav-vektors |
| DK2986635T3 (en) | 2013-04-18 | 2019-01-28 | Fond Telethon | EFFECTIVE DELIVERY OF BIG GENES THROUGH DUAL-AAV VECTORS |
| HUE052676T2 (hu) | 2013-10-11 | 2021-05-28 | Massachusetts Eye & Ear Infirmary | Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik |
| US10577627B2 (en) | 2014-06-09 | 2020-03-03 | Voyager Therapeutics, Inc. | Chimeric capsids |
| EP3215191B1 (en) | 2014-11-05 | 2024-08-14 | Voyager Therapeutics, Inc. | Aadc polynucleotides for the treatment of parkinson's disease |
| CN114717264A (zh) | 2014-11-14 | 2022-07-08 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| KR20230145206A (ko) | 2014-11-14 | 2023-10-17 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
| EP4134375A1 (en) * | 2015-07-30 | 2023-02-15 | Massachusetts Eye & Ear Infirmary | Ancestral adeno associated virus sequences and uses thereof |
| IL314171A (en) | 2015-09-28 | 2024-09-01 | Univ Florida | Methods and compositions for antibody-evading virus vectors |
| AU2016362477A1 (en) | 2015-12-02 | 2018-06-14 | Voyager Therapeutics, Inc. | Assays for the detection of AAV neutralizing antibodies |
| AU2016370630B2 (en) * | 2015-12-14 | 2023-04-13 | The Trustees Of The University Of Pennsylvania | Adeno-associated viral vectors useful in treatment of spinal muscular atropy |
| EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| US10584337B2 (en) | 2016-05-18 | 2020-03-10 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
| IL297576B2 (en) | 2016-05-18 | 2024-02-01 | Voyager Therapeutics Inc | Compositions and methods of treating huntington's disease |
| JP6994018B2 (ja) * | 2016-07-26 | 2022-01-14 | バイオマリン ファーマシューティカル インコーポレイテッド | 新規アデノ随伴ウイルスキャプシドタンパク質 |
| WO2018039375A1 (en) | 2016-08-23 | 2018-03-01 | Akouos, Inc. | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
| EP3831281B1 (en) | 2016-08-30 | 2026-02-25 | The Regents of The University of California | Devices and systems for biomedical targeting and delivery |
| EP3618839A4 (en) | 2017-05-05 | 2021-06-09 | Voyager Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| MX2019013172A (es) | 2017-05-05 | 2020-09-07 | Voyager Therapeutics Inc | Composiciones y metodos para tratar la enfermedad de huntington. |
| WO2018209154A1 (en) * | 2017-05-10 | 2018-11-15 | Massachusetts Eye And Ear Infirmary | Methods and compositions for modifying assembly-activating protein (app)-dependence of viruses |
| CN110831611A (zh) | 2017-05-10 | 2020-02-21 | 马萨诸塞眼科耳科诊所 | 用于修饰病毒的组装活化蛋白(aap)依赖性的方法和组合物 |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| CA3070087A1 (en) | 2017-07-17 | 2019-01-24 | Voyager Therapeutics, Inc. | Trajectory array guide system |
| US11512327B2 (en) | 2017-08-03 | 2022-11-29 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of AAV |
| MX2020003042A (es) | 2017-09-29 | 2020-11-18 | Voyager Therapeutics Inc | Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa. |
| US20200231986A1 (en) * | 2017-09-29 | 2020-07-23 | Massachusetts Eye And Ear Infirmary | Production of adeno-associated viruses in insect cells |
| TW202413649A (zh) | 2017-10-16 | 2024-04-01 | 美商航海家醫療公司 | 肌萎縮性脊髓側索硬化症(als)之治療 |
| WO2019079242A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| IL325122A (en) | 2018-02-22 | 2026-02-01 | Akouos Inc | Compositions and methods for treating non-age-related hearing impairment in humans |
| MX2020010465A (es) | 2018-04-03 | 2021-01-08 | Vectores de virus para direccionamiento a tejidos oftalmicos. | |
| BR112020020266A2 (pt) | 2018-04-03 | 2021-01-19 | Stridebio, Inc. | Vetores de vírus com evasão de anticorpos |
| CA3095179A1 (en) | 2018-04-03 | 2019-10-10 | Stridebio, Inc. | Antibody-evading virus vectors |
| WO2019195701A1 (en) | 2018-04-05 | 2019-10-10 | Massachusetts Eye And Ear Infirmary | Methods of making and using combinatorial barcoded nucleic acid libraries having defined variation |
| KR20210008501A (ko) | 2018-05-09 | 2021-01-22 | 바이오마린 파머수티컬 인크. | 페닐케톤뇨증을 치료하는 방법 |
| IL278598B2 (en) | 2018-05-11 | 2025-11-01 | Massachusetts Eye & Ear Infirmary | Altering tissue tropism of adeno-associated viruses |
| TW202005978A (zh) | 2018-05-14 | 2020-02-01 | 美商拜奧馬林製藥公司 | 新穎肝靶向腺相關病毒載體 |
| CN112424359A (zh) | 2018-05-15 | 2021-02-26 | 沃雅戈治疗公司 | 用于治疗帕金森氏病的组合物和方法 |
| US12281321B2 (en) | 2018-09-28 | 2025-04-22 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| UY38407A (es) | 2018-10-15 | 2020-05-29 | Novartis Ag | Anticuerpos estabilizadores de trem2 |
| CN113727992A (zh) | 2019-03-21 | 2021-11-30 | 斯特里迪比奥公司 | 重组腺相关病毒载体 |
| WO2020223232A1 (en) * | 2019-04-29 | 2020-11-05 | The Trustees Of The University Of Pennsylvania | Novel aav capsids and compositions containing same |
| JP7707081B2 (ja) * | 2019-05-17 | 2025-07-14 | リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル | 網膜細胞を標的とした最適化された遺伝子治療 |
| CN110423778B (zh) * | 2019-07-26 | 2023-04-21 | 上海科技大学 | 一种逆行性重组2型腺相关病毒在感染螺旋神经元中的应用 |
| CA3153972A1 (en) | 2019-09-09 | 2021-03-18 | Massachusetts Eye And Ear Infirmary | Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav |
| WO2021073568A1 (en) * | 2019-10-16 | 2021-04-22 | Wuxi Apptec (Shanghai) Co., Ltd. | A novel aav variant |
| CN114207196B (zh) * | 2019-10-16 | 2024-01-26 | 上海药明康德新药开发有限公司 | 新的aav文库 |
| MX2022004353A (es) | 2019-10-17 | 2022-07-19 | Casete de transferencia de aav. | |
| CN114787180A (zh) | 2019-10-17 | 2022-07-22 | 斯特里迪比奥公司 | 用于治疗c型尼曼-匹克病的腺相关病毒载体 |
| CA3168055A1 (en) | 2020-02-21 | 2021-08-26 | Emmanuel John Simons | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
| CN115335704A (zh) * | 2020-05-12 | 2022-11-11 | 隆萨休斯敦股份有限公司 | 用于检测腺相关病毒的方法和试剂盒 |
| JP2023542614A (ja) | 2020-08-19 | 2023-10-11 | サレプタ セラピューティクス， インコーポレイテッド | レット症候群の治療のためのアデノ随伴ウイルスベクター |
| MX2023005446A (es) | 2020-11-11 | 2023-07-18 | European Molecular Biology Laboratory | Particulas virales modificadas para terapia genica. |
| CN117377771A (zh) | 2021-05-12 | 2024-01-09 | 特莱索恩基金会 | 载体系统 |
| CA3255627A1 (en) | 2022-05-06 | 2023-11-09 | Novartis Ag | NEW VP2 FUSION POLYPEPTIDES OF RECOMBINANT AAV |
| EP4705489A1 (en) * | 2023-04-24 | 2026-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Prediction of immunostimulatory potential of aav in a human preclinical model |
| WO2024249739A2 (en) * | 2023-05-31 | 2024-12-05 | Board Of Regents For Oklahoma Agricultural And Mechanical Colleges | Compositions and methods for homology-based derivation of structure-function relationships for protein families |
| WO2025171001A1 (en) | 2024-02-06 | 2025-08-14 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for improved production of aav viral vectors |
| WO2025188755A1 (en) | 2024-03-04 | 2025-09-12 | Kate Therapeutics, Inc. | Adeno-associated virus compositions for the treatment of duchenne muscular dystrophy |
| TW202548024A (zh) | 2024-03-19 | 2025-12-16 | 義大利商博雷亞醫療有限責任公司 | 靶向ｃｎｓ中之組織 |
| WO2025226842A1 (en) | 2024-04-24 | 2025-10-30 | Kate Therapeutics, Inc. | Expression control by drg-expressed mirnas |
| WO2025226841A1 (en) | 2024-04-24 | 2025-10-30 | Kate Therapeutics, Inc. | Gene therapy approach for treating disorders associated with tnnt2 |
| WO2026011008A1 (en) | 2024-07-02 | 2026-01-08 | Kate Therapeutics, Inc. | Expression control by skeletal muscle-expressed mirnas |
| WO2026011009A1 (en) | 2024-07-02 | 2026-01-08 | Kate Therapeutics, Inc. | Compositions and methods for muscle disorders |
| WO2026030242A1 (en) | 2024-07-29 | 2026-02-05 | Kate Therapeutics, Inc. | Adeno-associated virus compositions for the treatment of facioscapulohumeral muscular dystrophy |
| WO2026030244A1 (en) | 2024-07-30 | 2026-02-05 | Kate Therapeutics, Inc. | Adeno-associated virus compositions for the treatment of limb girdle muscular dystrophy 2a |
| WO2026050402A1 (en) | 2024-08-29 | 2026-03-05 | Kate Therapeutics, Inc. | Liver de-targeted muscle tropic capsids |
| WO2026150302A1 (en) | 2025-01-09 | 2026-07-16 | Novartis Ag | Novel aav rep/cap encoding constructs |
| CN120842333A (zh) * | 2025-06-20 | 2025-10-28 | 上海朗昇生物科技有限公司 | 工程化的腺相关病毒衣壳蛋白和载体及其用途 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US368925A (en) * | 1887-08-30 | Feed mechanism for sewing-machines | ||
| US242997A (en) * | 1881-06-14 | Reversible seat | ||
| US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| US5037384B2 (en) | 1988-01-12 | 1995-12-26 | Cornell Res Foundation Inc | Method and apparatus for the treatment of complicated retinal detachments |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5387484A (en) | 1992-07-07 | 1995-02-07 | International Business Machines Corporation | Two-sided mask for patterning of materials with electromagnetic radiation |
| WO1996017947A1 (en) | 1994-12-06 | 1996-06-13 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
| US5688676A (en) | 1995-06-07 | 1997-11-18 | Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| US5741683A (en) | 1995-06-07 | 1998-04-21 | The Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| CA2270285A1 (en) | 1996-12-18 | 1998-06-25 | Targeted Genetics Corporation | Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| WO2000024916A1 (en) | 1998-10-27 | 2000-05-04 | Crucell Holland B.V. | Improved aav vector production |
| DE19905501B4 (de) | 1999-02-10 | 2005-05-19 | MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie | Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels |
| US20040115621A1 (en) | 2000-02-18 | 2004-06-17 | Allen Rodrigo | Ancestral viruses and vaccines |
| US6692526B1 (en) | 2000-03-15 | 2004-02-17 | Michael E. Snyder | Ophthalmological surgery colorant and delivery system |
| AU2001270252B2 (en) | 2000-07-03 | 2007-02-08 | Catalent Pharma Solutions, Llc | Expression vectors |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| WO2003074714A1 (en) | 2002-03-05 | 2003-09-12 | Stichting Voor De Technische Wetenschappen | Baculovirus expression system |
| AU2003221733A1 (en) | 2002-04-17 | 2003-11-03 | University Of Florida Research Foundation, Inc. | Improved raav vectors |
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| EP1668143B1 (en) * | 2003-09-30 | 2013-03-20 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| DE23193606T1 (de) | 2005-04-07 | 2024-02-15 | The Trustees Of The University Of Pennsylvania | Verfahren zur erhöhung der funktion eines aav-vektors |
| US8388668B2 (en) | 2005-08-05 | 2013-03-05 | Gholam A. Peyman | Methods to regulate polarization of excitable cells |
| PT3272872T (pt) | 2005-10-20 | 2020-06-26 | Uniqure Ip Bv | Vetores aav melhorados produzidos em células de insetos |
| JP5745842B2 (ja) | 2007-06-19 | 2015-07-08 | ストラトス ゲノミクス インコーポレイテッド | 拡張によるハイスループット核酸配列決定 |
| AU2009215987B2 (en) | 2008-02-19 | 2015-01-22 | Uniqure Ip B.V. | Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| CA2754335C (en) | 2009-03-04 | 2019-12-24 | Medigene Ag | Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3 |
| WO2010136549A2 (en) | 2009-05-28 | 2010-12-02 | Deutsches Krebsforschungszentrum | Modified aav capsid polypeptides |
| US9631227B2 (en) | 2009-07-06 | 2017-04-25 | Trilink Biotechnologies, Inc. | Chemically modified ligase cofactors, donors and acceptors |
| SG10201605049QA (en) | 2011-05-20 | 2016-07-28 | Fluidigm Corp | Nucleic acid encoding reactions |
| CA2877962C (en) | 2012-06-29 | 2018-06-05 | Massachusetts Institute Of Technology | Massively parallel combinatorial genetics |
| EP2970946A4 (en) * | 2013-03-13 | 2016-09-07 | Philadelphia Children Hospital | ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF |
| WO2014144495A1 (en) | 2013-03-15 | 2014-09-18 | Abvitro, Inc. | Single cell bar-coding for antibody discovery |
| HUE052676T2 (hu) | 2013-10-11 | 2021-05-28 | Massachusetts Eye & Ear Infirmary | Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik |
| WO2016025878A1 (en) | 2014-08-14 | 2016-02-18 | Abbott Molecular Inc. | Multifunctional oligonucleotides |
| US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
| WO2016138496A1 (en) | 2015-02-27 | 2016-09-01 | Cellular Research, Inc. | Spatially addressable molecular barcoding |
| WO2016160908A1 (en) | 2015-03-30 | 2016-10-06 | Verily Life Sciences Llc | Methods for combining single cell profiling with combinatorial nanoparticle conjugate library screening |
| EP4134375A1 (en) * | 2015-07-30 | 2023-02-15 | Massachusetts Eye & Ear Infirmary | Ancestral adeno associated virus sequences and uses thereof |
| CN109688820B (zh) | 2016-06-24 | 2023-01-10 | 科罗拉多州立大学董事会（法人团体） | 用于生成条形码化组合文库的方法 |
| US20230048025A1 (en) | 2016-12-22 | 2023-02-16 | Oregon Health & Science University | Adeno associated viral vectors |
| WO2018209154A1 (en) * | 2017-05-10 | 2018-11-15 | Massachusetts Eye And Ear Infirmary | Methods and compositions for modifying assembly-activating protein (app)-dependence of viruses |
| CA3095179A1 (en) | 2018-04-03 | 2019-10-10 | Stridebio, Inc. | Antibody-evading virus vectors |
| US12281321B2 (en) | 2018-09-28 | 2025-04-22 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| WO2021154923A2 (en) | 2020-01-29 | 2021-08-05 | Voyager Therapeutics, Inc. | Methods and systems for producing aav particles |
| WO2022150634A2 (en) | 2021-01-08 | 2022-07-14 | Massachusetts Eye And Ear Infirmary | Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav |
-
2016
- 2016-07-29 EP EP22182170.5A patent/EP4134375A1/en not_active Withdrawn
- 2016-07-29 EP EP21161372.4A patent/EP3872085B1/en active Active
- 2016-07-29 HU HUE21161372A patent/HUE061388T2/hu unknown
- 2016-07-29 AU AU2016298394A patent/AU2016298394C1/en active Active
- 2016-07-29 CA CA3126951A patent/CA3126951A1/en not_active Abandoned
- 2016-07-29 CA CA2994160A patent/CA2994160C/en active Active
- 2016-07-29 FI FIEP21161372.4T patent/FI3872085T3/fi active
- 2016-07-29 US US15/748,738 patent/US10738087B2/en active Active
- 2016-07-29 JP JP2018504699A patent/JP7166168B2/ja active Active
- 2016-07-29 PL PL21161372.4T patent/PL3872085T3/pl unknown
- 2016-07-29 HK HK18113943.1A patent/HK1254848A1/zh unknown
- 2016-07-29 ES ES21161372T patent/ES2945427T3/es active Active
- 2016-07-29 LT LTEP21161372.4T patent/LT3872085T/lt unknown
- 2016-07-29 PT PT211613724T patent/PT3872085T/pt unknown
- 2016-07-29 NZ NZ778484A patent/NZ778484A/en unknown
- 2016-07-29 EP EP16831443.3A patent/EP3329017B1/en not_active Withdrawn - After Issue
- 2016-07-29 WO PCT/US2016/044819 patent/WO2017019994A2/en not_active Ceased
- 2016-07-29 CN CN201680057177.2A patent/CN108603235A/zh active Pending
- 2016-07-29 DK DK21161372.4T patent/DK3872085T5/da active
-
2020
- 2020-08-10 US US16/989,454 patent/US12227543B2/en active Active
-
2021
- 2021-06-16 JP JP2021099934A patent/JP7222028B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3329017B1 (en) | 2021-03-10 |
| WO2017019994A2 (en) | 2017-02-02 |
| HUE061388T2 (hu) | 2023-06-28 |
| EP3329017A2 (en) | 2018-06-06 |
| US20190100560A1 (en) | 2019-04-04 |
| AU2016298394B2 (en) | 2022-07-28 |
| FI3872085T3 (fi) | 2023-04-19 |
| EP4134375A1 (en) | 2023-02-15 |
| JP2021175397A (ja) | 2021-11-04 |
| DK3872085T3 (da) | 2023-04-03 |
| AU2016298394C1 (en) | 2024-02-15 |
| JP7222028B2 (ja) | 2023-02-14 |
| NZ778484A (en) | 2024-11-29 |
| CA2994160C (en) | 2021-08-10 |
| CA3126951A1 (en) | 2017-02-02 |
| JP7166168B2 (ja) | 2022-11-07 |
| JP2018521670A (ja) | 2018-08-09 |
| HK1254848A1 (zh) | 2019-07-26 |
| US12227543B2 (en) | 2025-02-18 |
| US20210017235A1 (en) | 2021-01-21 |
| CA2994160A1 (en) | 2017-02-02 |
| NZ739476A (en) | 2024-10-25 |
| EP3329017A4 (en) | 2018-12-26 |
| US10738087B2 (en) | 2020-08-11 |
| CN108603235A (zh) | 2018-09-28 |
| PT3872085T (pt) | 2023-04-13 |
| AU2016298394A1 (en) | 2018-02-22 |
| LT3872085T (lt) | 2023-05-10 |
| EP3872085A1 (en) | 2021-09-01 |
| ES2945427T3 (es) | 2023-07-03 |
| DK3872085T5 (da) | 2024-08-12 |
| EP3872085B1 (en) | 2023-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3872085T (pt) | Sequências de aav ancestrais e utilizações destas | |
| IL287825A (en) | Structures of sirp-alpha variant and their uses | |
| IL255577B (en) | Binding materials - tigit and their uses | |
| IL253433A0 (en) | Binders - tnfrsf and their uses | |
| SG11201706029VA (en) | Anti-senescence compounds and uses thereof | |
| ZA201801052B (en) | Combinations and uses thereof | |
| IL256020B (en) | Igfbp3 and uses thereof | |
| ZA201705456B (en) | Benzoxaborole compounds and uses thereof | |
| ZA201706293B (en) | Releasable fastener | |
| IL254241A0 (en) | Etv2 and its uses | |
| GB201718875D0 (en) | Autophagy-inhibiting compounds and uses thereof | |
| IL254287A0 (en) | Cyclic galanin analogs and uses thereof | |
| IL253459B (en) | Isoergoline compounds and their uses | |
| IL250175A0 (en) | A peptide derived from koc1 and a component containing it | |
| GB2545167B (en) | Cloches and use thereof | |
| GB201403765D0 (en) | ORCTL3 Sequences and their uses | |
| GB201517685D0 (en) | Velcro | |
| GB201517698D0 (en) | Velcro | |
| GB201514285D0 (en) | Velcro | |
| GB201500278D0 (en) | Novel combination and use | |
| GB201508993D0 (en) | Parasol bases |